This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Lehigh Valley NORML, and medical cannabis patients from across Pennsylvania, will hold the second in a series of monthly protests at the Department of Health (PaDOH) headquarters on Forster St. “Patients First: Fixing Medical Marijuana in PA” will commence on Wednesday November 13, 2019 from 08:30 AM-5:00 PM.
In 2019 this meant assessing the medical cannabis programs of 47 states, the District of Columbia, and four territories. Every year the ASA team and I spend a considerable amount of time formally comparing every medical cannabis program in the United States.
On Wednesday, September 25th, 2019, NORML testified at the DC Council Committee on Labor and Workforce Development in support of B23-0309 , the “Medical Marijuana Program Patient Employment Protection Amendment Act of 2019”, which seeks to expand workplace protections for medical cannabis patients in the District of Columbia.
Voter support for cannabis policy reforms remains strong, with a November 2019 Pew Research Poll finding that a full two-thirds of Americans support making cannabis legal, with 78% of Democrats and Democratic-leaning independents agreeing that cannabis should be legal, and 55% of Republicans in favor of legalizing cannabis access.
SB1719 allows “registered agents” for those patients physically unable to pick up or receive delivery of their medical cannabis, like those in hospice, assisted living facilities, and those who rely on home healthcare providers. Virginia NORML members meet with Senator Dave Marsden. “I am proud to be part of this effort.”
NORML Announces Plans for 2019 Conference and Lobby Day. David Phipps, communications director of Indiana Norml, said CBD oil can help with epilepsy, noting cases where some child patients went from over 100 seizures a day to near zero when they started taking CBD.” ” Read more from NORML.org ! .
With most state legislatures adjourned for the 2019 calendar year, the New Jersey legislature is one of just a few legislative bodies that are still in session. Advocates will be meeting with their representatives in Trenton on Monday, September 23, 2019, from 11:45AM – 3:00PM EDT.
In the Texas State Capitol Building, dozens of patients joined us to ask their legislators to coauthor legislation that makes the Texas Compassionate Use Program more inclusive and effective. Patients then broke out into groups by district and went to visit their legislative offices.
NORML Announces Plans for 2019 Conference and Lobby Day. “Virginia NORML is trying to make this search easier for patients. In order to register for Virginia’s medical cannabis program, patients must first receive a written certification from a registered physician. ” Read More from 10 WHEC !
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”
Steve Sisolak has signed legislation, Senate Bill 430 , expanding the pool of patients eligible for medical cannabis therapy. The measure allows patients diagnosed with anxiety disorders, autism, chronic pain, opioid dependency, and other conditions to obtain a recommendation for medical cannabis.
Since January, the advocates traveled across Sin City, completed a tour across the Battle Born State and to our nation’s capital on behalf of medical patients and those who have been unfairly affected by the War on Drugs. Initiated a patient voucher program for eligible patients. Established a NORML chapter in Reno.
Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. Chris Goldstein, a writer and regional organizer for NORML, has gathered Pa.
Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. million) came from sales by caregivers to patients. Only the state’s lobster industry and potato industry bring in more annual revenue.
NORML Announces Plans for 2019 Conference and Lobby Day. ” Read more from NORML.org ! “Adding a condition for which a physician could recommend medical marijuana instead of an opioid is a safer pain management tool that will be useful for both our doctors and patients.” ” Read more from the Denver Post !
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
State lawmakers have approved a series of bills reducing penalties for marijuana possession offenses and strengthening and expanding legal protections for medical cannabis patients. Once signed into law, the reduced penalties take effect on July 1, 2019. ” The effective date of the Act is July 1, 2019. DECRIMINALIZATION.
There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. For these famous medical cannabis patients and supporters, it is something that can improve quality of life and which should be made readily available to anyone in need. 1) Patrick Stewart. It’s tricky.”.
Adapted from The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience (Routledge, 2019) by Michelle Newhart and William Dolphin. As with all things involving social controversy, dispute over what to properly call the plant known by the botanical name Cannabis Sativa L. comes with the territory.
Next, the presence of large cash transactions places law enforcement, tax regulators, consumers, and patients at heightened risk of exposure to the virus.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
The NM Political Report | Medical Cannabis Program
AUGUST 29, 2020
Amid the COVID-19 pandemic the New Mexico Department of Health approved rules that put into practice a state law allowing medical cannabis patients from other states to buy, possess and use medical cannabis in New Mexico. The law was passed in 2019 as part of a massive statutory change for medical cannabis.
The issue of adulterants in cannabis vape products has once again resurfaced as the Pennsylvania Office of Medical Marijuana issued a notice to medical cannabis patients on February 4, 2022 advising them of a recall of over 500 different products containing substances not suitable for inhalation.
In Congress this week Senator Cory Booker (D-NJ), along with Representatives Barbara Lee (D-CA) and Ro Khanna (D-CA), introduced The Marijuana Justice Act of 2019, to remove marijuana from the Controlled Substances Act and incentivize states to end the racially disparate criminalization of marijuana consumers. AR resident? CO resident?
It passed the House on 2/27/2019 by a vote of 209-147. 175 would allow physicians to recommend marijuana to any patient they believe would benefit from its therapeutic use, and HB 461 would allow physicians to recommend medical marijuana to patients suffering from moderate to severe insomnia, moderate to severe anxiety, or Lyme disease.
Senate Bill 2023 expands the state’s medical cannabis program by adding several new qualifying conditions, allowing physicians assistants and advanced practice registered nurses to recommend medical cannabis to their patients, allowing minor patients to have up to three caregivers instead of two, among other changes.
Guam became the first US territory to send a bill legalizing the adult-use of marijuana to the governor’s desk in 2019. Governor Gary Herbert (R) of Utah signed legislation into law that strengthens protections for medical cannabis patients and further improves upon the state’s new medical cannabis access program.
Minnesota investigators identified the presence of the oil additive in 24 of the products used by 11 patients with the lung disease. Virtually all of the patients interviewed in the study acknowledged obtaining THC vape products on the underground market.
Regulate Like Alcohol : The Regulate Marijuana Like Alcohol Act of 2019 — (HR 420) seeks to deschedule cannabis from the Controlled Substances Act, thus permitting state governments to regulate these activities as they see fit. This means that some patients must travel long distances and pay exorbitant prices to obtain their medicine.
For terminally ill patients living out their final days, cannabis can make a world of difference –but they’ve traditionally faced barriers attempting to use the plant medicine in hospital settings. That changed for patients in California on Tuesday, Sept. 28 when Gov. However, the majority of U.S. That was the question Sen. .”
According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. The results?
Introduced was The Ending Federal Marijuana Prohibition Act of 2019, to remove marijuana from the federal Controlled Substances list and allow states the freedom to regulate marijuana as they choose, without federal interference. “The Ending Federal Prohibition Act is about acknowledging political, scientific, and economic reality. .
There are now over 3 million medical cannabis patients across the country; ninety-one percent of Americans now live in states with some form of access to medical cannabis, while sixty-six of American adults are in favor of full legalization. It is time for a new approach to end the federal conflict on cannabis policy.
Springfield, IL : Just prior to the closing of the 2019 legislative session, both chambers of the Illinois statehouse passed the Cannabis Regulation and Tax Act (HB1438-SFA2) to legalize cannabis and regulate it’s production, manufacture, and distribution. It also expands access and rights for qualified medical patients.
Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies.
In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.
There are four bills pertaining to the legalization of cannabis during the 2019 session of the Kentucky General Assembly. Jason Nemes, R-33, is sponsoring a medical cannabis bill (HB 136) that allows doctors to recommend cannabis therapy as part of patients’ treatment regimens. 9 during a news conference. “And guess what?
Legislation is pending, Assembly Bill 2355, to protect registered medical marijuana patients from employment discrimination. Mississippi voters will receive the opportunity to vote this November on whether or not to allow medical marijuana for patients with debilitating medical conditions. AK resident? California. Mississippi.
Regulate Nationally : The Regulate Marijuana Like Alcohol Act of 2019 (HR 420) seeks to deschedule cannabis from the Controlled Substances Act, thus permitting state governments to regulate these activities as they see fit. Click here to email your lawmakers in support of allowing patients to smoke medical cannabis. Actions to Take.
A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. .
10 would expand patients’ access to medical cannabis through several means. It would allow doctors the discretion to recommend medical cannabis to any patient they believe with benefit, phases out sales taxes on medical cannabis, and establishes additional legal protections for patients and caregivers. Companion bills S.
Once again, Nevada NORML has remained hard at work, advocating for both patient access and rights as well as the criminal justice reform that this country desperately requires.
It seeks to redefine allowed dosage limitations and formulations, and expand patient access and reduce patient cost by adding nurse practitioners and physician assistants to the list of those authorized to issue written certifications to patients. Marijuana policy should be evidence based.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content